Center-Authored Papers

Filters: Author is Hsieh, Andrew C  [Clear All Filters]
2015
Hsieh AC, Nguyen HG, Wen L, Edlind MP, Carroll PR, Kim W, Ruggero D.  2015.  Cell type-specific abundance of 4EBP1 primes prostate cancer sensitivity or resistance to PI3K pathway inhibitors.. Science signaling. 8(403):ra116. Abstract
2017
Wei XX, Hsieh AC, Kim W, Friedlander T, Lin AM, Louttit M, Ryan CJ.  2017.  A Phase I Study of Abiraterone Acetate Combined with BEZ235, a Dual PI3K/mTOR Inhibitor, in Metastatic Castration Resistant Prostate Cancer.. The oncologist. Abstract
Bluemn EG, Coleman IM, Lucas JM, Coleman RT, Hernandez-Lopez S, Tharakan R, Bianchi-Frias D, Dumpit RF, Kaipainen A, Corella AN et al..  2017.  Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF Signaling.. Cancer cell. 32(4):474-489.e6. Abstract
2019
Liu Y, Horn JL, Banda K, Goodman AZ, Lim Y, Jana S, Arora S, Germanos AA, Wen L, Hardin WR et al..  2019.  The androgen receptor regulates a druggable translational regulon in advanced prostate cancer.. Science translational medicine. 11(503) Abstract
Kuppers DA, Arora S, Lim Y, Lim AR, Carter LM, Corrin PD, Plaisier CL, Basom R, Delrow JJ, Wang S et al..  2019.  N-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis.. Nature communications. 10(1):4596. Abstract